🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST

Aytu BioPharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
58.5257.5766.3865.1873.896.67
Revenue Growth
-8.12%-13.28%1.84%-11.68%-23.66%47.29%
Cost of Revenue
21.4620.7520.5516.1321.5746.39
Gross Profit
37.0736.8245.8349.0552.2350.28
Selling, General & Admin
4542.6438.2942.0449.7769.88
Research & Development
--1.332.773.9812.66
Amortization of Goodwill & Intangibles
2.812.493.683.683.695.84
Operating Expenses
47.8145.1343.2948.4957.4488.39
Operating Income
-10.74-8.322.540.57-5.21-38.1
Interest Expense
-1.79-1.9-3.7-5.06-5.15-0.01
Other Non Operating Income (Expenses)
-7.55-4.02-2.22-3.135.220.86
EBT Excluding Unusual Items
-20.08-14.23-3.38-7.63-5.14-37.26
Merger & Restructuring Charges
---2.1-2.16--
Impairment of Goodwill
------65.8
Asset Writedown
---8.26--2.73-7.66
Other Unusual Items
----0.590.581.82
Pretax Income
-20.08-14.23-13.75-10.38-7.29-108.89
Income Tax Expense
0.020.020.442.140.26-0.11
Earnings From Continuing Operations
-20.1-14.25-14.18-12.52-7.55-108.78
Earnings From Discontinued Operations
--0.62-3.32-9.5-
Net Income
-20.1-14.25-13.56-15.84-17.05-108.78
Net Income to Common
-20.1-14.25-13.56-15.84-17.05-108.78
Net Income Growth
------
Shares Outstanding (Basic)
15126631
Shares Outstanding (Diluted)
15126631
Shares Change
107.63%96.17%13.40%65.81%127.22%75.54%
EPS (Basic)
-1.36-1.16-2.16-2.86-5.11-74.01
EPS (Diluted)
-1.36-1.16-2.16-2.86-5.11-74.01
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
3.63.25-2.17-1.72-5.13-28.82
Free Cash Flow Per Share
0.240.26-0.34-0.31-1.54-19.61
Gross Margin
63.34%63.95%69.04%75.26%70.77%52.02%
Operating Margin
-18.35%-14.44%3.82%0.87%-7.05%-39.42%
Profit Margin
-34.34%-24.76%-20.43%-24.31%-23.11%-112.53%
Free Cash Flow Margin
6.14%5.65%-3.26%-2.63%-6.95%-29.82%
EBITDA
-6.49-4.397.917.292.49-27.96
EBITDA Margin
-11.10%-7.62%11.92%11.18%3.38%-28.92%
D&A For EBITDA
4.253.935.386.737.710.15
EBIT
-10.74-8.322.540.57-5.21-38.1
EBIT Margin
-18.35%-14.44%3.82%0.87%-7.05%-39.42%
Advertising Expenses
-----13.6
SEC Filings: 10-K · 10-Q